Skip to main content

Table 5 Types of treatment centers associated with treatment response after topotecan and cyclophosphamide containing induction therapy (multivariate analysis)

From: Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study

Health care system Response ≥ 90% Response < 90% Crude OR
(95% CI)
p-value Adjusted OR
(95% CI)
p-value
University-based 37 (45.7) 44 (54.3) 1   1  
Community-based 5 (19.2) 21 (80.8) 3.53
(1.21–10.28)
0.021 3.13
(1.05–9.37)
0.041
  1. Notes: Data are categorical variables and presented as number (%). Multivariate analysis was calculated using multiple logistic regression adjusted for age, gender, grade of tumor differentiation, MYCN status, Shimada histology, serum NSE and urine VMA. p-value < 0.05 is considered as statistical significance
\